Nabriva Therapeutics plc reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Dublin, Ireland
SEC filing record 1 source field available
Fiscal year end
31 December
Nabriva Therapeutics plc has filed 695 SEC EDGAR filings since 14 May 2015

SEC filing history

Showing 76-100 of 112 matching filings.

Per page
25
Current page
4
8-K File 001-37558

8-K

Filing date
06 Nov 2018
Reporting date
06 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37558

8-K

Filing date
31 Oct 2018
Reporting date
31 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-37558

8-K/A

Filing date
10 Sep 2018
Reporting date
23 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37558

8-K

Filing date
09 Aug 2018
Reporting date
09 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37558

8-K

Filing date
07 Aug 2018
Reporting date
01 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37558

8-K

Filing date
01 Aug 2018
Reporting date
26 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37558

8-K

Filing date
25 Jul 2018
Reporting date
23 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37558

8-K

Filing date
19 Jun 2018
Reporting date
13 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37558

8-K

Filing date
21 May 2018
Reporting date
21 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37558

8-K

Filing date
20 Apr 2018
Reporting date
20 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37558

8-K

Filing date
27 Mar 2018
Reporting date
26 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37558

8-K

Filing date
16 Mar 2018
Reporting date
16 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37558

8-K

Filing date
16 Mar 2018
Reporting date
16 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37558

8-K

Filing date
21 Feb 2018
Reporting date
21 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37558

8-K

Filing date
02 Feb 2018
Reporting date
31 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37558

8-K

Filing date
09 Nov 2017
Reporting date
09 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37558

8-K

Filing date
07 Nov 2017
Reporting date
07 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37558

8-K

Filing date
20 Sep 2017
Reporting date
19 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37558

8-K

Filing date
18 Sep 2017
Reporting date
18 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37558

8-K

Filing date
15 Sep 2017
Reporting date
15 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37558

8-K

Filing date
31 Aug 2017
Reporting date
31 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37558

8-K

Filing date
21 Aug 2017
Reporting date
17 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37558

8-K

Filing date
11 Aug 2017
Reporting date
09 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37558

8-K

Filing date
07 Aug 2017
Reporting date
07 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37558

8-K

Filing date
21 Jul 2017
Reporting date
23 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .